Determinants of downloads and citations for articles published in intensive care medicine

J. F. Timsit; G. Citerio; M. Lavilloniere; A. Perner; M. Smith; S. Ruckly; M. Bassetti; J. Bakker; D. Benoit; J. R. Curtis; G. Doig; M. Herridge; S. Jaber; L. Papazian; M. Peters; P. Singer; M. Soares; A. Torres; A. Viellard-Baron; E. Azoulay

doi:10.1186/2197-425X-3-S1-A863

Determinants of downloads and citations for articles published in intensive care medicine

J. F. Timsit^*, G. Citerio, M. Lavilloniere, A. Perner, M. Smith, S. Ruckly, M. Bassetti, J. Bakker, D. Benoit, J. R. Curtis, G. Doig, M. Herridge, S. Jaber, L. Papazian, M. Peters, P. Singer, M. Soares, A. Torres, A. Viellard-Baron, E. Azoulay

^*Corresponding author for this work

Clinical Departments

Research output: Contribution to journal › Comment/debate

Original language	English
Article number	A863
Journal	Intensive Care Medicine Experimental
Volume	3
DOIs	https://doi.org/10.1186/2197-425X-3-S1-A863
State	Published - 1 Oct 2015

Access to Document

10.1186/2197-425X-3-S1-A863

Cite this

Timsit, J. F., Citerio, G., Lavilloniere, M., Perner, A., Smith, M., Ruckly, S., Bassetti, M., Bakker, J., Benoit, D., Curtis, J. R., Doig, G., Herridge, M., Jaber, S., Papazian, L., Peters, M., Singer, P., Soares, M., Torres, A., Viellard-Baron, A., & Azoulay, E. (2015). Determinants of downloads and citations for articles published in intensive care medicine. Intensive Care Medicine Experimental, 3, Article A863. https://doi.org/10.1186/2197-425X-3-S1-A863

@article{cf2e332e0259477ba984a379741568ec,

title = "Determinants of downloads and citations for articles published in intensive care medicine",

author = "Timsit, {J. F.} and G. Citerio and M. Lavilloniere and A. Perner and M. Smith and S. Ruckly and M. Bassetti and J. Bakker and D. Benoit and Curtis, {J. R.} and G. Doig and M. Herridge and S. Jaber and L. Papazian and M. Peters and P. Singer and M. Soares and A. Torres and A. Viellard-Baron and E. Azoulay",

note = "Funding Information: Dr Larsson receives support from the Swedish Heart-Lung Foundation (Hj{\"a}rt-Lungfonden, grant number 20190247), the Swedish Research Council (Vetenskapsr{\aa}det, grant number 2019-00977), and the Swedish Research Council for Health, Working Life and Welfare (Forte, grant number 2018-00123). Dr Gill is funded by the Wellcome 4i Clinical PhD Program at Imperial College London. Dr Burgess is supported by a Sir Henry Dale Fellowship jointly funded by the Wellcome Trust and the Royal Society (award number 204623/Z/16/Z). Drs Burgess and Butterworth report funding from Novartis relating to the investigation of lipoprotein(a). The funder had no influence on the content of the investigation or the decision to publish. This work was supported by core funding from the UK Medical Research Council (MR/L003120/1), the British Heart Foundation (RG/13/13/30194; RG/18/13/33946), the National Institute for Health Research [Cambridge Biomedical Research Centre at the Cambridge University Hospitals NHS Foundation Trust] and Health Data Research UK, which is funded by the UK Medical Research Council, Engineering and Physical Sciences Research Council, Economic and Social Research Council, Department of Health and Social Care (England), Chief Scientist Office of the Scottish Government Health and Social Care Directorates, Health and Social Care Research and Development Division (Welsh Government), Public Health Agency (Northern Ireland), British Heart Foundation and Wellcome. The views expressed are those of the authors and not necessarily those of the National Health Service, the National Institute for Health Research, or the Department of Health and Social Care. Funding Information: Dr Larsson receives support from the Swedish Heart-Lung Foundation (Hj{\"a}rt-Lungfonden, grant number 20190247), the Swedish Research Council (Vetenskapsr{\aa}det, grant number 2019-00977), and the Swedish Research Council for Health, Working Life and Welfare (Forte, grant number 2018-00123). Dr Gill is funded by the Wellcome 4i Clinical PhD Program at Imperial College London. Dr Burgess is supported by a Sir Henry Dale Fellowship jointly funded by the Wellcome Trust and the Royal Society (award number 204623/Z/16/Z). Drs Burgess and Butterworth report funding from Novartis relating to the investigation of lipoprotein(a). The funder had no influence on the content of the investigation or the decision to publish. This work was supported by core funding from the UK Medical Research Council (MR/L003120/1), the British Heart Foundation (RG/13/13/30194; RG/18/13/33946), the National Institute for Health Research [Cambridge Biomedical Research Centre at the Cambridge University Hospitals NHS Foundation Trust] and Health Data Research UK, which is funded by the UK Medical Research Council, Engineering and Physical Sciences Research Council, Economic and Social Research Council, Department of Health and Social Care (England), Chief Scientist Office of the Scottish Government Health and Social Care Directorates, Health and Social Care Research and Development Division (Welsh Government), Public Health Agency (Northern Ireland), British Heart Foundation and Wellcome. The views expressed are those of the authors and not necessarily those of the National Health Service, the National Institute for Health Research, or the Department of Health and Social Care. Funding Information: Dr Butterworth has received grants from AstraZeneca, Biogen, Bioverativ, Merck, and Sanofi outside of this work. The other authors report no conflicts.",

year = "2015",

month = oct,

day = "1",

doi = "10.1186/2197-425X-3-S1-A863",

language = "אנגלית",

volume = "3",

journal = "Intensive Care Medicine Experimental",

issn = "2197-425X",

publisher = "Springer Open",

}

Timsit, JF, Citerio, G, Lavilloniere, M, Perner, A, Smith, M, Ruckly, S, Bassetti, M, Bakker, J, Benoit, D, Curtis, JR, Doig, G, Herridge, M, Jaber, S, Papazian, L, Peters, M, Singer, P, Soares, M, Torres, A, Viellard-Baron, A & Azoulay, E 2015, 'Determinants of downloads and citations for articles published in intensive care medicine', Intensive Care Medicine Experimental, vol. 3, A863. https://doi.org/10.1186/2197-425X-3-S1-A863

TY - JOUR

T1 - Determinants of downloads and citations for articles published in intensive care medicine

AU - Timsit, J. F.

AU - Citerio, G.

AU - Lavilloniere, M.

AU - Perner, A.

AU - Smith, M.

AU - Ruckly, S.

AU - Bassetti, M.

AU - Bakker, J.

AU - Benoit, D.

AU - Curtis, J. R.

AU - Doig, G.

AU - Herridge, M.

AU - Jaber, S.

AU - Papazian, L.

AU - Peters, M.

AU - Singer, P.

AU - Soares, M.

AU - Torres, A.

AU - Viellard-Baron, A.

AU - Azoulay, E.

N1 - Funding Information: Dr Larsson receives support from the Swedish Heart-Lung Foundation (Hjärt-Lungfonden, grant number 20190247), the Swedish Research Council (Vetenskapsrådet, grant number 2019-00977), and the Swedish Research Council for Health, Working Life and Welfare (Forte, grant number 2018-00123). Dr Gill is funded by the Wellcome 4i Clinical PhD Program at Imperial College London. Dr Burgess is supported by a Sir Henry Dale Fellowship jointly funded by the Wellcome Trust and the Royal Society (award number 204623/Z/16/Z). Drs Burgess and Butterworth report funding from Novartis relating to the investigation of lipoprotein(a). The funder had no influence on the content of the investigation or the decision to publish. This work was supported by core funding from the UK Medical Research Council (MR/L003120/1), the British Heart Foundation (RG/13/13/30194; RG/18/13/33946), the National Institute for Health Research [Cambridge Biomedical Research Centre at the Cambridge University Hospitals NHS Foundation Trust] and Health Data Research UK, which is funded by the UK Medical Research Council, Engineering and Physical Sciences Research Council, Economic and Social Research Council, Department of Health and Social Care (England), Chief Scientist Office of the Scottish Government Health and Social Care Directorates, Health and Social Care Research and Development Division (Welsh Government), Public Health Agency (Northern Ireland), British Heart Foundation and Wellcome. The views expressed are those of the authors and not necessarily those of the National Health Service, the National Institute for Health Research, or the Department of Health and Social Care. Funding Information: Dr Larsson receives support from the Swedish Heart-Lung Foundation (Hjärt-Lungfonden, grant number 20190247), the Swedish Research Council (Vetenskapsrådet, grant number 2019-00977), and the Swedish Research Council for Health, Working Life and Welfare (Forte, grant number 2018-00123). Dr Gill is funded by the Wellcome 4i Clinical PhD Program at Imperial College London. Dr Burgess is supported by a Sir Henry Dale Fellowship jointly funded by the Wellcome Trust and the Royal Society (award number 204623/Z/16/Z). Drs Burgess and Butterworth report funding from Novartis relating to the investigation of lipoprotein(a). The funder had no influence on the content of the investigation or the decision to publish. This work was supported by core funding from the UK Medical Research Council (MR/L003120/1), the British Heart Foundation (RG/13/13/30194; RG/18/13/33946), the National Institute for Health Research [Cambridge Biomedical Research Centre at the Cambridge University Hospitals NHS Foundation Trust] and Health Data Research UK, which is funded by the UK Medical Research Council, Engineering and Physical Sciences Research Council, Economic and Social Research Council, Department of Health and Social Care (England), Chief Scientist Office of the Scottish Government Health and Social Care Directorates, Health and Social Care Research and Development Division (Welsh Government), Public Health Agency (Northern Ireland), British Heart Foundation and Wellcome. The views expressed are those of the authors and not necessarily those of the National Health Service, the National Institute for Health Research, or the Department of Health and Social Care. Funding Information: Dr Butterworth has received grants from AstraZeneca, Biogen, Bioverativ, Merck, and Sanofi outside of this work. The other authors report no conflicts.

PY - 2015/10/1

Y1 - 2015/10/1

UR - http://www.scopus.com/inward/record.url?scp=85132496185&partnerID=8YFLogxK

U2 - 10.1186/2197-425X-3-S1-A863

DO - 10.1186/2197-425X-3-S1-A863

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.comment???

AN - SCOPUS:85132496185

SN - 2197-425X

VL - 3

JO - Intensive Care Medicine Experimental

JF - Intensive Care Medicine Experimental

M1 - A863

ER -

Determinants of downloads and citations for articles published in intensive care medicine

Access to Document

Other files and links

Cite this